Blood transfusion

Blood And Blood Components Global Market Report 2022: Growing Prevalence of Diseases and Increasing Numbers of Road Accidents and Traumas Driving Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 31, 2022
Cardiology, Biotechnology, Surgery, Oncology, Health, Infectious Diseases, Hospitals, Other Health, WNV, Mortality, Blood transfusion, Safety, Application, Awareness, TTI, Accident, Collection, Blood, Infection, US, Male, HIV, Center, HTLV-III, Trauma, Viral hepatitis, Prevalence, Centers for Disease Control and Prevention, Risk, Haemophilia A, Growth, Injury, Patient, Medical device, Vaccine, EU, West Nile virus

The "Blood And Blood Components Global Market Report 2022, By Product, By End-Users, By Application, By Blood Components" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Blood And Blood Components Global Market Report 2022, By Product, By End-Users, By Application, By Blood Components" report has been added to ResearchAndMarkets.com's offering.
  • The growing prevalence of diseases and increasing numbers of road accidents and traumas are increasing the demand for blood and thus driving the market.
  • The blood and blood components market is restrained by the growing risk of developing or transferring an infection while the blood is transmitted to the patients.
  • The most prominent trend that has been witnessed in the blood and blood components market is the growing number of collaborations between the players involved in the market.

Americans Takes Part in World Blood Donation Record Attempt to Save Lives

Retrieved on: 
Tuesday, August 23, 2022
South Dayi District, Blood transfusion, Awareness, Calendar, Council, Blood, NEW, Population, World Blood Donor Day, Social justice, Memorial Blood Centers, Council of the Notariats of the European Union, Muhammad, Nightclub, Medical device

NEW YORK, Aug. 23, 2022 /PRNewswire/ -- On Saturday August 27, thousands of Americans will attempt to break the world record for the most blood donations in one calendar day.

Key Points: 
  • NEW YORK, Aug. 23, 2022 /PRNewswire/ -- On Saturday August 27, thousands of Americans will attempt to break the world record for the most blood donations in one calendar day.
  • #GlobalBloodHeroes Dayis a worldwide campaign to save lives and build greater awareness about the urgent need to donate blood.
  • Just one blood donation can help save three lives.
  • One blood donation can save up to three lives, and it only takes an hour of your time."

Team Rubicon Announces Expansion of International Division to Serve Global Humanitarian Needs

Retrieved on: 
Thursday, August 18, 2022
International Team, Marshall Islands, De la Cruz, TR, Molecular epidemiology, Shanghai High School International Division, Mortality, CEO, Face, Refugee crisis, Investment, United States International Programming to Ukraine and Neighboring Regions, Hygiene, Blood transfusion, Infection, WASH, Knowledge, Triage, Patient, Injury, COVID-19, Team Rubicon, Disaster, Dengue fever, Partnership, Boy Scouts of America, Disease, WHO, Volunteering, Entrepreneurship, Pharmaceutical industry, Management, Risk management, Medicine, Health

LOS ANGELES, Aug. 18, 2022 /PRNewswire/ -- Veteran-led humanitarian organization Team Rubicon (TR) announces an expanded global focus through significant investments in International Programs on World Humanitarian Day, August 19, 2022. Specifically, Team Rubicon is increasing team capacity and expanding service partnerships and safely providing additional programs such as international medical support and training, water sanitation and hygiene (WASH), and crisis innovation.

Key Points: 
  • LOS ANGELES, Aug. 18, 2022 /PRNewswire/ -- Veteran-led humanitarian organization Team Rubicon (TR) announces an expanded global focus through significant investments in International Programs on World Humanitarian Day, August 19, 2022.
  • Art delaCruz, CEO of Team Rubicon, stated, "Team Rubicon is proud to have Under Armour and 1P.org as the key partners of our International Team.
  • Their early investment will fuel the expansion of the organization's international services and enable Team Rubicon to support vulnerable communities across the globe."
  • Team Rubicon is a veteran-led humanitarian organization that serves global communities before, during, and after disasters and crises.

Vuzix M400 Smart Glasses Begin Use Case in Japan for Ambulance Emergency Medical Care

Retrieved on: 
Tuesday, August 16, 2022
U.S. Securities and Exchange Commission, Vital signs, Risk, Juntendo University, Emergency, Forward-looking statement, Technology, IP, Facebook, Blood transfusion, M400, Hospital, ECG, Smartglasses, Research, Communication, Emergency medical technician, Nursing, Degenerative disease, Patient, Company, Twitter, Blood, Private Securities Litigation Reform Act, CES, NASDAQ, Intention, News, Thrombolysis, AE, Wireless, Augmented reality, Ambulance, Consumer Electronics Show, Solution, MD, AR, Pharmaceutical industry, Health insurance, Vuzix

In this trial, emergency medical technicians (EMTs) are using Vuzix M400 smart glasses to convey medical information from the ambulance to the hospital from the moment of patient engagement to their delivery to the hospital.

Key Points: 
  • In this trial, emergency medical technicians (EMTs) are using Vuzix M400 smart glasses to convey medical information from the ambulance to the hospital from the moment of patient engagement to their delivery to the hospital.
  • Additionally, in-hospital doctors can better instruct accurate in-transit emergency treatment (blood transfusion, surgery, thrombolytic therapy, intravascular treatment, etc.)
  • Currently, Vuzix smart glasses are being used by select ambulances under the jurisdiction of the Shunto Izu Fire Department.
  • Vuzix is a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets.

Pennies by the Inch® Celebrates a Century of Helping Kids at Intermountain Primary Children’s Hospital

Retrieved on: 
Monday, August 8, 2022
Intermountain, Glycosylation, Hospital, Pneumonia, Primary, Diagnosis, Utah Jazz, Child, Blood transfusion, Birth, Intubation, Temple Square, RN, Light, Whole genome sequencing, Critical care, Nursing, Patient, Â, School, Dehydration, Parent, Epilepsy, Sepsis, Cortical blindness, Music, The Walt Disney Company, Thought, MBA, Protein, Cardiac arrest, Volunteering, Health insurance, Amusement arcade, Toy

Pennies by the Inch has endeared generations of children to Primary Childrens Hospital and created lifelong stewards of the hospital, said Janet DeWolfe, executive director of the Intermountain Foundation at Primary Childrens Hospital.

Key Points: 
  • Pennies by the Inch has endeared generations of children to Primary Childrens Hospital and created lifelong stewards of the hospital, said Janet DeWolfe, executive director of the Intermountain Foundation at Primary Childrens Hospital.
  • All donations to Pennies by the Inch benefit the area of greatest need at Primary Childrens Hospital, which is bringing critical care expertise to patients such as two-year-old Belle.
  • Its amazing to me to think that Pennies by the Inch is celebrating 100 years or 36,500 days of helping families like mine at Primary Childrens Hospital.
  • More information about how to give to Pennies by the Inch, start a fundraiser, and help patients at Primary Childrens Hospital is at PenniesByTheInch.org .

Mednow’s Liver Care Canada Partners With HepCURE With the Goal of Eliminating Hepatitis C in Canada by 2030

Retrieved on: 
Wednesday, June 29, 2022
Online Retail, Retail, Health, Infectious Diseases, Technology, Software, Pharmaceutical, Acupuncture, TSX Venture Exchange, Death, Federation, Patient, Review, Transport, Sex, CEO, Liver, Needle, Infection, Prescription, Liver disease, Company, Viral hepatitis, Industry, Disease, Goal, Phrase, Hepatitis C virus, Hepatitis C, World, HIV, Medicine, Risk, Partnership, Blood transfusion, Technology, Body piercing, Organization, World Health Organization, Tattoo, HCV, Vitamin, Pharmacy, Time, Pedicure, Christian Marcoux, News, Knowledge, Program, Forward-looking statement, WHO, Pharmaceutical industry, Health insurance, Hospital, Vaccine

This is the first time two providers that treat hepatitis C have joined forces to share their knowledge and expertise to make a significant impact on elimination of hepatitis C in Canada.

Key Points: 
  • This is the first time two providers that treat hepatitis C have joined forces to share their knowledge and expertise to make a significant impact on elimination of hepatitis C in Canada.
  • Liver Care Canada will now offer their patients access to HepCUREs programming and services to further improve medication adherence and optimize treatment outcomes.
  • Furthermore it will expand the Liver Care Business outside of Ontario to the rest of Canada.
  • Mednow earlier this year acquired Liver Care Canada, and now looks to expand and scale that business nationally by leveraging Mednows existing national pharmacy footprint.

The Blood Connection Warns of Blood Shortage Heading into July 4th Holiday Week

Retrieved on: 
Thursday, June 23, 2022
Community, Population, Panic, Soy milk, Congress, World Blood Donor Day, Regulation of tobacco by the U.S. Food and Drug Administration, CEO, Survival, Hospital, Celebrate Freedom Week, Milk, GLOBE, Blood transfusion, Cancer, Food, Patient, TBC, Blood, Medical device, Pharmaceutical industry

A different, yet similar, urgent supply issue is happening right now: The Blood Connection (TBC) fears it could be running on a 2-3-day supply of blood very soon.

Key Points: 
  • A different, yet similar, urgent supply issue is happening right now: The Blood Connection (TBC) fears it could be running on a 2-3-day supply of blood very soon.
  • To make matters worse, there is no substitute for blood.
  • Thats why blood must be continuously donated for real patients in local hospitals, who desperately need blood transfusions every day.
  • While youre enjoying the holiday, please remember to make a blood donation for your fellow Americans who are depending on blood for surgeries and cancer treatments.

NICE recommends use of Hansa Biopharma's Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

Retrieved on: 
Thursday, June 16, 2022
Antibody, Hansa, Veni, vidi, vici, Mortality, Transplant, Royal commission, Safety, State, Priority, Decision-making, HLA, Kidney, MHRA, Health care, CEO, Survival, National Institute for Health and Care Excellence, European Medicines Agency, Company, Cancer, Chronic kidney disease, Research, Medication, Nasdaq Stockholm, Human leukocyte antigen, Degenerative disease, European, Kidney transplantation, Kidney failure, Program, Donation, ESRD, National Institute, Blood transfusion, Quality of life, Nasdaq, Immunoglobulin G, Dialysis, Adult, Kidney disease, Medicine, EMA, Patient, Database, NICE, Kidney Research UK, EU, European Commission, Risk, Pharmaceutical industry, Dentistry, Medical device, Agency

The recommendation marks an important milestone for patients in England, Wales and Northern Ireland, as appropriate specialized transplant centres will be able to use Idefirixto enable transplantation for highly sensitized patients, currently highly unlikely to receive a lifesaving compatible kidney transplant.

Key Points: 
  • The recommendation marks an important milestone for patients in England, Wales and Northern Ireland, as appropriate specialized transplant centres will be able to use Idefirixto enable transplantation for highly sensitized patients, currently highly unlikely to receive a lifesaving compatible kidney transplant.
  • "We welcome this decision, which will allow new opportunities for certain highly sensitized patients to qualify for a life-altering transplant, and gain freedom from dialysis.
  • Decision making around who has access to the treatment is key, and the lifespan of the transplanted kidneys will need to be carefully monitored."
  • Hansa has developed a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme therapy, which has been shown to enable kidney transplantation in highly sensitized patients.

Etihad Cargo Signs MOU for Sustainable Pharmaceutical Transportation Solutions

Retrieved on: 
Tuesday, June 14, 2022
Transport, Animal, ABU, SDD, WHO, Varian Medical Systems, Doh, Technology, Etihad Airways, Blood management, Sustainability, Center, Abu Dhabi Investment Office, Red, Partnership, Solution, International Red Cross and Red Crescent Movement, Emirate, Electrolux, UNICEF, MOU, Blood transfusion, IATA, Abu Dhabi Ports, Carbon, Khalifa University, Department of Health (Abu Dhabi), Ministry of Health and Medical Education, Temperature, Senior, HOPE, Vaccine, Hospital, Medication, Department, System, ADQ, Environment, Aviation, Atmosphere, Ministry, University, Pharmaceutical industry, Health

Etihad Cargo has signed an MOU with B Medical Systems to become the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals and life sciences.

Key Points: 
  • Etihad Cargo has signed an MOU with B Medical Systems to become the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals and life sciences.
  • ABU DHABI, United Arab Emirates, June 14, 2022 /PRNewswire/ --Etihad Cargo, the cargo and logistics arm of Etihad Aviation Group, has entered into a memorandum of understanding (MOU) with B Medical Systems.
  • Etihad Cargo will collaborate with Luxembourg-based manufacturer and global distributor of medical refrigeration devices, B Medical Systems, to develop more sustainable temperature-controlled container units that work utilising passive cooling technology.
  • Etihad Cargo is the cargo and logistics arm of the Etihad Aviation Group.

Etihad Cargo Signs MOU for Sustainable Pharmaceutical Transportation Solutions

Retrieved on: 
Tuesday, June 14, 2022
Transport, Animal, ABU, SDD, WHO, Varian Medical Systems, Doh, Technology, Etihad Airways, Blood management, Sustainability, Center, Abu Dhabi Investment Office, Red, Partnership, Solution, International Red Cross and Red Crescent Movement, Emirate, Electrolux, UNICEF, MOU, Blood transfusion, IATA, Abu Dhabi Ports, Carbon, Khalifa University, Department of Health (Abu Dhabi), Ministry of Health and Medical Education, Temperature, Senior, HOPE, Vaccine, Hospital, Medication, Department, System, ADQ, Environment, Aviation, Atmosphere, Ministry, University, Pharmaceutical industry, Health

Etihad Cargo has signed an MOU with B Medical Systems to become the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals and life sciences.

Key Points: 
  • Etihad Cargo has signed an MOU with B Medical Systems to become the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals and life sciences.
  • ABU DHABI, United Arab Emirates, June 14, 2022 /PRNewswire/ --Etihad Cargo, the cargo and logistics arm of Etihad Aviation Group, has entered into a memorandum of understanding (MOU) with B Medical Systems.
  • Etihad Cargo will collaborate with Luxembourg-based manufacturer and global distributor of medical refrigeration devices, B Medical Systems, to develop more sustainable temperature-controlled container units that work utilising passive cooling technology.
  • Etihad Cargo is the cargo and logistics arm of the Etihad Aviation Group.